Learning Objectives: 

  • To describe the role of the ANA (antinuclear antibody) testing in the new ACR/EULAR classification criteria
  • To describe the technologies used to assess ANA levels
  • To describe strategies for optimal use of ANA testing in the clinical setting
  •  

Disclosures: None

CME CodeLUPQUC

Location: 3rd floor conference room by the purple elevators and virtually on WebEx
Directions: If you are having trouble accessing WebEx, please contact Cassy Sims at cas206@duke.edu 

Streaming: Via WebEx. Link: https://dukemed.webex.com/dukemed/j.php?MTID=m57511734eb4f3e4f0423f94de8a7eb34 

Meeting Number/Access Code: 120 459 7417 (you will not need this if you use link above)

Call-in number: 1-650-479-3207

Session date: 
07/20/2021 - 8:00am to 9:00am EDT

Please login or register to take this course.
Room Number: 
WebEx (or 3rd floor conference room, Duke South, purple zone -- for faculty & fellows only)
Speaker Name: 
Dr. David Pisetsky